The cellular and molecular events of central nervous system remyelination

M Dubois-Dalcq, R Armstrong

Research output: Contribution to journalReview articlepeer-review

57 Scopus citations

Abstract

Central nervous system (CNS)* regeneration is a subject of great interest, particularly in diseases causing a dramatic loss of neurons. However, some CNS diseases do not affect neurons but damage other cells, such as the myelin-forming cells--called oligodendrocytes--which are also crucial to the harmonious function of the nervous system. Diseases in which oligodendrocytes and myelin are attacked can cause devastating neurological dysfunction which is sometimes followed by recovery and myelin repair or remyelination. The question of the regeneration potential of oligodendrocytes in experimental and human demyelinating diseases such as multiple sclerosis has been debated for a long time. Present evidence suggests that oligodendrocyte precursor cells persist in the adult CNS and that oligodendrocyte regeneration can occur but may be limited by ongoing disease processes. Here we will briefly review recent advances which have broadened our understanding of the cellular and molecular events of CNS remyelination.

Original languageEnglish
Pages (from-to)569-76
Number of pages8
JournalBioEssays : news and reviews in molecular, cellular and developmental biology
Volume12
Issue number12
DOIs
StatePublished - Dec 1990

Keywords

  • Age Factors
  • Animals
  • Autoimmune Diseases/physiopathology
  • Cells, Cultured
  • Central Nervous System/physiology
  • Demyelinating Diseases/physiopathology
  • Disease Models, Animal
  • Growth Substances/physiology
  • Guinea Pigs
  • Humans
  • Mice
  • Multiple Sclerosis/pathology
  • Myelin Proteins/metabolism
  • Myelin Sheath/physiology
  • Nerve Regeneration
  • Oligodendroglia/metabolism
  • Rats

Cite this